{"transactions":[{"id":1000436,"issuer":{"id":8263,"kind":"organization","name":"Apimeds Pharmaceuticals US, Inc."},"owners":[{"id":73228,"kind":"person","name":"Koo Jakap","position":1,"cik":"0002041972","reported_name":"Koo Jakap","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-11-13T23:37:41.000Z","date":"2025-11-11","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option shall vest in quarterly installments beginning October 1, 2025, such that the award shall be fully vested after three years subject to the reporting person's employment continuing through and on each vesting date. This option is not exercisable until stockholder approval is obtained to approve an amendment to the Company's incentive plan (the \"Plan\") to increase the number of shares of common stock available for issuance under the Plan. The shares of common stock subject to the option shall vest in full vest upon the occurrence of a Change in Control, as defined in the Plan."}],"balance_after":10000,"derivative":{"exercise_price":2.67,"expiration_date":"2035-11-11","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0002041972-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894525/000204197225000004/primary_doc.xml","form_type":"4"}},{"id":1016946,"issuer":{"id":8263,"kind":"organization","name":"Apimeds Pharmaceuticals US, Inc."},"owners":[{"id":73228,"kind":"person","name":"Koo Jakap","position":1,"cik":"0002041972","reported_name":"Koo Jakap","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-10-17T23:17:33.000Z","date":"2025-10-15","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option shall vest in quarterly installments beginning October 1, 2025, such that the award shall be fully vested after three years subject to the reporting person's service to the issuer continuing through and on each vesting date. This option is not exercisable until stockholder approval is obtained to approve an amendment to the issuer's incentive plan (the \"Plan\") to increase the number of shares of common stock available for issuance under the Plan. The shares of common stock subject to the option shall vest in full upon the occurrence of a Change in Control, as defined in the Plan."}],"balance_after":3000,"derivative":{"exercise_price":1.92,"expiration_date":"2035-10-15","underlying":"Common Stock, par value $0.01 per share","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0002041972-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894525/000204197225000003/primary_doc.xml","form_type":"4"}},{"id":1140625,"issuer":{"id":8263,"kind":"organization","name":"Apimeds Pharmaceuticals US, Inc."},"owners":[{"id":73228,"kind":"person","name":"Koo Jakap","position":1,"cik":"0002041972","reported_name":"Koo Jakap","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-20T20:38:00.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":5780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full and become exercisable on 05/16/2026."}],"balance_after":5780,"derivative":{"exercise_price":1.73,"expiration_date":"2035-05-16","underlying":"Common Stock, par value $0.01 per share","underlying_shares":5780},"source":{"system":"sec-edgar","filing":"0002041972-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894525/000204197225000001/primary_doc.xml","form_type":"4"}},{"id":1149450,"issuer":{"id":8263,"kind":"organization","name":"Apimeds Pharmaceuticals US, Inc."},"owners":[{"id":73228,"kind":"person","name":"Koo Jakap","position":1,"cik":"0002041972","reported_name":"Koo Jakap","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2025-05-14T21:58:18.000Z","date":"2025-05-12","kind":"purchase","planned":false,"acquired":true,"shares":28500,"price":1.99,"value":56715.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Apimeds Pharmaceuticals US, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were sold in multiple transactions at prices ranging from $1.9774 to $2.2000, inclusive."}],"balance_after":643885,"source":{"system":"sec-edgar","filing":"0001474506-25-000090","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894525/000147450625000090/primary_doc.xml","form_type":"4"}}]}